Meeting
2023 ASCO Genitourinary Cancers Symposium
Characterizing the immune phenotype of FGFR3 mutated upper tract urothelial carcinoma (UTUC) using single-cell (sc)RNA-sequencing (seq).
Authors
Andrew B Katims
Memorial Sloan Kettering Cancer Center, New York, NY
Andrew B Katims , Fengshen Kuo , Peter Reisz , Andrew Tracey , Jasmine Thomas , Wesley Yip , Taha Merghoub , Bernard H. Bochner , Eugene J. Pietzak , David B. Solit , A. Ari Hakimi , Kwanghee Kim , Jonathan Coleman
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Poster Session B: Prostate Cancer and Urothelial Carcinoma
Track
Urothelial Carcinoma,Prostate Cancer - Advanced
Sub Track
Translational Research, Tumor Biology, Biomarkers, and Pathology
Citation
J Clin Oncol 41, 2023 (suppl 6; abstr 558)
DOI
10.1200/JCO.2023.41.6_suppl.558
Abstract #
558
Poster Bd #
N1
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Breakthrough
Effect of low FGFR3 but high CD8 T cell infiltrated immune micro-environment on treatment response with pembrolizumab in upper tract urothelial carcinoma.
First Author: Keisuke Shigeta
Poster
2022 ASCO Annual Meeting
Analysis of the contribution of macrophages to the overall tumor PD-L1 microenvironment using a screening multi-tumor tissue microarray and rapid multiplex fluorescence digital phenotyping approach.
First Author: Marie Cumberbatch
Poster
2022 ASCO Genitourinary Cancers Symposium
Upper tract urothelial carcinoma transcriptome profiling and immune microenvironment characterization.
First Author: Wesley Yip
Poster
2019 Gastrointestinal Cancers Symposium
Single-cell analysis of immune-microenvironment and immune-tumor interaction in human gastric cancers.
First Author: Michele Goh